IRL790

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	6

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 6 of 6 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-002010-41-IT (EUCTR)	21/01/2021	25/01/2021	Phase II trial investigating Uncontrollable voluntary movements in PD	A randomized, double-blind, placebo-controlled phase IIB study evaluating the efficacy of mesdopetam ...	Parkinson's disease dyskinesia MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Par ...	Product Name: mesdopetam Product Code: [IRL790] INN or Proposed INN: mesdopetam Product Name: Mesdopeta ...	Integrative Research Laboratories Sweden AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	140	Phase 2	France;United States;Serbia;Poland;Israel;Italy
2	EUCTR2020-002010-41-FR (EUCTR)	22/12/2020	09/09/2020	NA	A randomized, double-blind, placebo-controlled phase IIB study evaluating the efficacy of mesdopetam ...	Parkinson's disease dyskinesia MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Par ...	Product Name: mesdopetam Product Code: IRL790 INN or Proposed INN: Mesdopetam Product Name: mesdopetam P ...	Integrative Research Laboratories Sweden AB (IRLAB)	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	140	Phase 2	United States;Serbia;France;Poland;Israel;Italy
3	EUCTR2017-003458-18-SE (EUCTR)	23/01/2019	10/12/2018	A clinical trial to study the effects of IRL790 in Parkinson's disease dyskinesia	A randomised, double-blind, placebo-controlled, phase IIA study evaluating the efficacy and tolerabi ...	Parkinson's disease dyskinesia MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Par ...	Product Name: IRL790 Product Code: IRL790 INN or Proposed INN: IRL790	Integrative Research Laboratories AB (IRLAB)	NULL	Not Recruiting			Female: yes Male: yes	74	Phase 2	Sweden
4	NCT03368170 (ClinicalTrials.gov)	April 12, 2018	5/12/2017	Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia	A Randomized, Placebo-controlled, Phase IIa Study Evaluating the Efficacy and Tolerability of IRL790 ...	Parkinson Disease	Drug: Mesdopetam (IRL790)	Integrative Research Laboratories AB	The Clinical Trial Company	Completed	18 Years	79 Years	All	75	Phase 2	Sweden;United Kingdom
5	EUCTR2017-003458-18-GB (EUCTR)	19/12/2017	27/09/2017	A clinical trial to study the effects of IRL790 in Parkinson's disease dyskinesia	A randomised, double-blind, placebo-controlled, phase IIA study evaluating the efficacy and tolerabi ...	Parkinson's disease dyskinesia MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Par ...	Product Name: IRL790 Product Code: IRL790 INN or Proposed INN: IRL790	Integrative Research Laboratories AB (IRLAB)	NULL	Not Recruiting			Female: yes Male: yes	74	Phase 2	United Kingdom;Sweden
6	NCT03531060 (ClinicalTrials.gov)	November 8, 2016	10/4/2018	A Clinical Study of IRL790in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskine ...	A Randomised, Double-blind, Placebo-controlled, Phase Ib Study Evaluating the Safety and Tolerabilit ...	Parkinson Disease	Drug: IRL790;Drug: Placebo	Integrative Research Laboratories AB	NULL	Completed	50 Years	85 Years	All	15	Phase 1/Phase 2	NULL

First Previous1Next Last